The draft rules mean that anyone who manipulates human genes in adults or embryos is responsible for adverse outcomes

Quick Read

The FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints

Quick Read

The shocking announcement of genetically modified babies creates an opportunity to overhaul the nation’s science, argue Ruipeng Lei and colleagues

Quick Read

How well-meaning donations end up fueling an unproven, virtually unregulated $2 billion stem cell industry

Quick Read

The agency ruled that Dengvaxia, can only be used in individuals aged 9 to 16 living in parts of the United States where the dengue virus is endemic. Furthermore, the vaccine can only be given to children and teens who have had one previous laboratory-confirmed case of dengue

Quick Read

The genome is static, but our ability to analyze it and interpret it is undergoing dramatic change,” said James Evans, a geneticist at the University of North Carolina in Chapel Hill

Quick Read

How an obsolete medical device with a security flaw became a must-have for some patients with type 1 diabetes. In 2014, a few hackers realized that the security flaw in certain Medtronic pumps could be exploited for a DIY revolution.

Quick Read

A prominent pediatrician and medical researcher in the Philippines has been indicted over the failed—and many say premature—introduction of Dengvaxia, a vaccine against dengue that was yanked from the Philippine market in 2017 because of safety issues

Quick Read